SharesGrow 7-Criteria Score
All 7 criteria scored · valuation-related highlighted on this page
Trulieve Cannabis Corp. (TCNNF) .
本页证实的标准:
- VALUE (100/100, 通过) — 分析师目标价暗示上行空间 (+601.5%).
- 分析师共识目标价 $47.21 (+601.5% 上行空间) — 华尔街分析师认为存在显著上行潜力。
SharesGrow 综合评分： 49/100 其中 2/7 项标准通过。
SharesGrow 7-Criteria Score
✓
价值
100/100
Price-to-Earnings & upside
Proven by this page
~
健康
50/100
Debt-to-Equity & liquidity
→ Health
估值概览 — TCNNF
估值倍数
P/E (TTM)0.0
前瞻 P/EN/A
PEG 比率N/A
前瞻 PEGN/A
P/B 比率0.00
P/S 比率1.07
EV/EBITDA0.0
每股数据
EPS (TTM)$-0.62
每股账面价值$0.00
每股营收$6.28
每股自由现金流$0.00
收益率与内在价值
盈利收益率N/A
股息收益率0.00%
分析师目标价$47.21 (+601.5%)
P/E Ratio & Earnings Yield
每股收益 (EPS) 历史
| Year |
EPS（稀释） |
营收 |
净利润 |
净利润率 |
| 2016 |
$0.00 |
$161.15K |
$-7.33K |
-4.5% |
| 2017 |
$0.00 |
$19.78M |
$-36.35K |
-0.2% |
| 2018 |
$0.42 |
$102.82M |
$42.97M |
41.8% |
| 2019 |
$1.54 |
$252.82M |
$178.03M |
70.4% |
| 2020 |
$0.53 |
$521.53M |
$63M |
12.1% |
| 2021 |
$0.12 |
$938.39M |
$18.03M |
1.9% |
| 2022 |
$-1.09 |
$1.24B |
$-205.1M |
-16.5% |
| 2023 |
$-2.84 |
$1.13B |
$-526.8M |
-46.7% |
| 2024 |
$-0.82 |
$1.19B |
$-155.11M |
-13.1% |
| 2025 |
$-0.62 |
$1.2B |
$-118.42M |
-9.9% |
